Sign in
LYCA Stock Price, Chart, Stats & News
Lycia Therapeutics Inc.
Save
Lycia Therapeutics Inc. (LYCA) does not currently pay a dividend.
1.58B
Market cap
–
Current P/E
–
Forward P/E
LYCA chart
About
Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.
Similar securities
Based on sector and market capitalization
Report issue